Dysfunction of endothelial protein C activation in severe meningococcal sepsis

New England Journal of Medicine

Volumn 345, Issue 6, 2001, Pages 408-416

  Faust, Saul N ^a   Levin, Michael ^a   Harrison, Odile B ^a   Goldin, Robert D ^a   Lockhart, Marion S ^b   Kondaveeti, Sheila ^a   Laszik, Zoltan ^c   Esmon, Charles T ^b,c,d   Heyderman, Robert S ^e  

^a ST MARY S HOSPITAL   (United Kingdom)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; PROTEIN C; PROTEIN S; RECEPTOR PROTEIN; THROMBOMODULIN;

ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; PETECHIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURPURA; SEPSIS; THROMBOSIS;

ANTITHROMBIN III; ANTITHROMBINS; BACTEREMIA; BIOPSY; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DOWN-REGULATION; ENDOTHELIUM; HUMANS; MENINGOCOCCAL INFECTIONS; MICROSCOPY, ELECTRON; NEISSERIA MENINGITIDIS; PEPTIDE HYDROLASES; PROTEIN C; PROTEIN S; PURPURA, SCHOENLEIN-HENOCH; RECEPTORS, CELL SURFACE; SKIN; THROMBOMODULIN;

EID: 0035833529     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200108093450603     Document Type: Article

References (66)

1. Global epidemiology of meningococcal disease
2. Emergency management of meningococcal disease
3. Pathogenesis of meningococcal infections
4. New therapies for severe meningococcal disease but better outcomes?
5. Pathophysiology of meningococcal sepsis in children
6. Purpura fulminans
7. Disseminated intravascular coagulation and purpura fulminans secondary to infection
8. Skin manifestations of meningococcal infection
9. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis
10. Induction of human endothelial tissue factor expression by Neisseria meningitidis: The influence of bacterial killing and adherence to the endothelium
11. Coagulation system and platelets are fully activated in uncomplicated sepsis
12. Disseminated intravascular coagulation
13. The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease
14. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
15. Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates
16. Age-related differences in outcome and severity of DIC in children with septic shock and purpura
17. Protein S and C alterations in acutely ill patients
18. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease
19. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
20. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counter-inflammatory mediators in children with meningococcal septic shock
21. Types 1 and 2 plasminogen activator inhibitor and tumor necrosis factor alpha in patients with sepsis
22. The protein C pathway: New insights
23. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate
24. Postinfectious purpura fulminans caused by an autoantibody directed against protein S
25. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
26. Efficacy and safety of recombinant human activated protein C for severe sepsis
27. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency
28. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease
29. Validation of the Glasgow Meningococcal Septicemia Prognostic Score: A 10-year retrospective survey
30. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions
31. Pediatric Risk of Mortality (PRISM) score
32. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies
33. Human protein C receptor is present primarily on endothelium of large blood vessels: Implications for the control of the protein C pathway
34. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections
35. Identification of functional endothelial protein C receptor in human plasma
36. Two ELISA's for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency
37. Severe protein C deficiency in congenital thrombotic disease - Description of an immunoenzymological assay for protein C determination
38. Enzyme linked immunosorbent assay for measuring antithrombin III
39. Direct detection of activated protein C in blood from human subjects
40. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor
41. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
42. The role of neutrophil elastase in human pulmonary artery endothelial cell injury
43. Endothelial protein C receptor
44. Endothelial cell injury, as quantified by the soluble thrombomodulin level, predicts sepsis/multiple organ dysfunction syndrome after blunt trauma
45. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure
46. Increased circulating thrombomodulin in children with septic shock
47. Meningococcal host cell interactions in the skin of children with purpura fulminans: Variation in the expression of capsule and type IV pili
48. Pathogenesis of cutaneous lesions in acute meningococcemia in humans: Light, immunofluorescent, and electron microscopic studies of skin biopsy specimens
49. Treatment of meningococcal disease in childhood
50. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis
51. Endothelial adhesion molecule expression and its inhibition by recombinant bactericidal/permeability-increasing protein are influenced by the capsulation and lipooligosaccharide structure of Neisseria meningitidis
52. Reduction of the anticoagulant activity of glycosaminoglycans on the surface of the vascular endothelium by endotoxin and neutrophils: Evaluation by an amidolytic assay
53. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils
54. Thrombomodulin structure and function
55. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: Lack of correlation with thrombomodulin suggests involvement of different pathological processes
56. The soluble endothelial protein C receptor binds to activated neutrophils: Involvement of proteinase-3 and CD11b/CD18
57. Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans
58. Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia
59. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock
60. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation
61. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
62. Protein C in the treatment of coagulopathy in meningococcal disease
63. Current drug treatment strategies for disseminated intravascular coagulation
64. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia
65. Time course of hemostatic abnormalities in sepsis and its relation to outcome
66. Protein C, protein S and C4b-binding protein in severe infection and septic shock